期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Infection related membranoproliferative glomerulonephritis secondary to anaplasmosis:A case
1
作者 Maulik K Lathiya Praveen Errabelli +1 位作者 Salvatore Mignano Susan M Cullinan 《World Journal of Nephrology》 2023年第3期66-72,共7页
BACKGROUND Anaplasmosis is a tick-borne disease with a range of clinical manifestations,from a flu-like illness with fever and myalgias to a severe systemic disease with multisystem organ failure.Although renal involv... BACKGROUND Anaplasmosis is a tick-borne disease with a range of clinical manifestations,from a flu-like illness with fever and myalgias to a severe systemic disease with multisystem organ failure.Although renal involvement is not a common presentation,there have been few cases reporting acute kidney injury from Anaplasmosis.CASE SUMMARY We present a 55-year-old female with anaplasmosis who developed acute kidney injury due to membranoproliferative glomerulonephritis(MPGN).The patient originally presented with cough and shortness of breath.She was admitted to the hospital with a diagnosis of community acquired pneumonia and received antibiotics.During the hospital course she developed severe acute renal failure.Initial serological work up didn’t provide any conclusive diagnosis.Hence,she underwent kidney biopsy which showed MPGN pattern suggesting autoimmune,multiple myeloma or infectious etiology.Extensive work up was undertaken which was negative for autoimmune diseases,vasculitis panel,paraproteinemias but tested positive for IgG anaplasma with high titers indicating Anaplasmosis.CONCLUSION Our case shows a unique presentation of severe acute renal failure from MPGN from tick borne illness.MPGN is usually seen with autoimmune diseases,hepatitis C virus infections,paraproteinemias.Hence,we suggest that tick borne illness should also be considered when evaluating acute renal failure cases in tick borne prevalent regions. 展开更多
关键词 Acute kidney injury membranoproliferative glomerulonephritis TICK-BORNE ANAPLASMOSIS Case report
下载PDF
Rituximab therapy for primary glomerulonephritis: Report on two cases
2
作者 Fabrizio Fabrizi Donata Cresseri +4 位作者 Giovanni B Fogazzi Gabriella Moroni Patrizia Passerini Paul Martin Piergiorgio Messa 《World Journal of Clinical Cases》 SCIE 2015年第8期736-742,共7页
The evidence in the medical literature on the efficacy and safety of rituximab therapy for primary glomerulonephritis is limited and controversial. We describe two male Caucasian patients with rapidly progressive kidn... The evidence in the medical literature on the efficacy and safety of rituximab therapy for primary glomerulonephritis is limited and controversial. We describe two male Caucasian patients with rapidly progressive kidney failure due to primary proliferative glomerulonephritis. Both of them received high-dose intravenous corticosteroids and oral cyclophosphamide with limited benefit. The first patient(hepatitis C virus-negative mixed cryoglobulinemia) underwent plasma-exchange with intravenous immunoglobulins; he showed significant benefit on kidney function(he became dialysis independent with serum creatinine going back to 1.6 mg/d L) after one rituximab pulse even if urinary abnormalities were still present. No improvement in renal function or urinary changes occurred in the second patient. Both these individuals developed sepsis over the follow-up, the first patient died two months after rituximab therapy. This report is in keeping with the occurrence of severe infections after rituximab therapy in patients with renal impairment at baseline and concomitant high-dose steroids. 展开更多
关键词 CHRONIC KIDNEY disease Cryoglobulinemic VASCULITIS membranoproliferative GLOMERULONEPHRITIS RITUXIMAB
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部